Allianz SE Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Allianz SE purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,231 shares of the medical equipment provider’s stock, valued at approximately $1,698,000.

A number of other hedge funds also recently bought and sold shares of the business. Allstate Corp acquired a new stake in Intuitive Surgical in the 4th quarter valued at $5,476,000. Brown Brothers Harriman & Co. lifted its position in shares of Intuitive Surgical by 26.9% in the fourth quarter. Brown Brothers Harriman & Co. now owns 3,373 shares of the medical equipment provider’s stock valued at $1,761,000 after acquiring an additional 714 shares in the last quarter. DnB Asset Management AS increased its position in shares of Intuitive Surgical by 8.0% during the fourth quarter. DnB Asset Management AS now owns 100,531 shares of the medical equipment provider’s stock worth $52,473,000 after purchasing an additional 7,406 shares in the last quarter. Alerus Financial NA raised its stake in Intuitive Surgical by 177.1% in the 4th quarter. Alerus Financial NA now owns 9,678 shares of the medical equipment provider’s stock valued at $5,052,000 after purchasing an additional 6,186 shares during the last quarter. Finally, Level Four Advisory Services LLC lifted its holdings in Intuitive Surgical by 18.3% in the 4th quarter. Level Four Advisory Services LLC now owns 894 shares of the medical equipment provider’s stock valued at $467,000 after purchasing an additional 138 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Finally, Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Trading Down 3.2 %

ISRG stock opened at $491.84 on Friday. The business’s fifty day moving average price is $556.28 and its 200 day moving average price is $532.68. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $175.18 billion, a PE ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.